幹細胞アッセイ市場：製品、アッセイ、用途、地域別、2024年～2031年

幹細胞アッセイ市場の評価、2024年～2031年

再生治療や個別化医療へのニーズの高まりは、幹細胞アッセイ市場を推進する要因の一つです。Verified Market Researchのアナリストによると、幹細胞アッセイ市場は予測期間中に78億1,000万米ドルの評価額に達し、2023年の約19億3,000万米ドルを上回ると予測されています。

毒物学や創薬における幹細胞調査の利用が拡大していることも、幹細胞アッセイ市場を促進している要因の一つです。2024年から2031年までのCAGRは19.07%です。

幹細胞アッセイ市場定義/概要

幹細胞アッセイは、幹細胞の特性や挙動を評価するための実験技術です。幹細胞の自己複製能、多様な細胞種への分化能、増殖能を調べるために、管理された条件下で幹細胞を検査します。幹細胞アッセイは生物医学研究や再生医療において重要な役割を担っており、その応用範囲は創薬や薬剤開発から毒性学的スクリーニングや疾患モデリングにまで及ぶ。

さらに幹細胞アッセイは、幹細胞の分化や機能に対する治療薬候補の影響を判定することで、医薬品開発に役立っています。また、これらのアッセイは、発生過程の研究、薬理学的毒性のスクリーニング、がんや神経疾患などの疾病原因の調査にも利用されています。

幹細胞アッセイ市場の成長に影響を与える側面とは？

幹細胞研究における絶え間ない発展と、幹細胞の単離・培養・分化に関する画期的な研究開発が主な推進力となっています。これらの技術的進歩は幹細胞アッセイの効率と有効性を高め、創薬や再生医療、基礎研究など様々な用途への応用をより魅力的なものにしています。3次元細胞培養技術、ハイスループット・スクリーニング手法、イメージングや分析ツールの進歩などの革新はすべて、市場拡大の原動力となっています。

再生医療への関心の高まりや、心血管系疾患、神経疾患、糖尿病など様々な疾患の治療に対する幹細胞の可能性が、幹細胞アッセイの需要を牽引しています。政府、事業会社、学術機関は、治療への応用を研究するために幹細胞研究に急速に投資しており、幹細胞を用いた治療の効率性や安全性を評価するための検査に対する需要を生み出しています。

さらに、慢性疾患や遺伝性疾患の世界の増加により、新薬や治療法の開発が必要とされています。幹細胞はそのような治療法を生み出す可能性のある選択肢の一つであり、疾患モデリングや薬剤開発、個別化医療において幹細胞アッセイに対する需要が高まっています。幹細胞アッセイに対するニーズは、学術界や製薬会社が病気の原因究明や新たな治療法のテストに取り組む中で高まっています。

幹細胞アッセイの技術的問題は市場の成長に影響を与えるか？

幹細胞研究の進歩にもかかわらず、幹細胞を目的の細胞種に効率よく分化させること、幹細胞培養の安定性と純度を維持すること、複数の研究室間でのアッセイ法の再現性を確保することなど、技術的・科学的な課題は依然として多く残されています。このような課題は幹細胞アッセイの信頼性や有効性に影響を及ぼし、手技の標準化や一貫した結果を得ることを困難にし、市場の拡大を制限しています。

幹細胞アッセイ法の開発・実施には、専門的な機器や試薬、そして専門家への多大な投資が必要です。このようなアッセイにかかる高コストは、経営資源の限られた学術機関や中小企業にとってはハードルとなります。さらに、幹細胞研究は長期に渡るものであり、幹細胞を用いた医薬品の商業的可能性についても不確実性があるため、大きな投資リスクとなります。このような金銭的な障害が幹細胞アッセイビジネスの成長を妨げ、その拡大を制限しています。

目次

第1章 幹細胞アッセイの世界市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 幹細胞アッセイの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 幹細胞アッセイの世界市場：製品別

• 概要
• 試薬とキット
• 器具

第6章 幹細胞アッセイの世界市場：用途別

• 概要
• 再生医療と治療
• 臨床研究
• 創薬と開発

第7章 幹細胞アッセイの世界市場：アッセイ別

• 概要
• 細胞同定アッセイ
• 生存能または細胞毒性アッセイ
• アポトーシスアッセイ
• 単離・精製アッセイ
• その他

第8章 幹細胞アッセイの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 幹細胞アッセイの世界市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Thermo Fisher Scientific
• Perkinelmer
• Stemcell Technologies
• Merck
• Bio-Rad Laboratories
• Agilent Technologies

第11章 付録

• 関連調査

Stem Cell Assay Market Valuation - 2024-2031

The growing need for regenerative therapies and personalized medicine is one factor propelling the stem cell assay market. According to the analyst from Verified Market Research, the stem cell assay market is estimated to reach a valuation of USD 7.81 Billion over the forecast period, surpassing around USD 1.93 Billion valued in 2023.

The growing use of stem cell research in toxicology and drug discovery is another factor propelling the market for stem cell assays. It enables the market to grow at a CAGR of 19.07% from 2024 to 2031.

Stem Cell Assay Market: Definition/Overview

A stem cell assay is a laboratory technique for assessing the properties and behavior of stem cells. It entails testing stem cells in controlled conditions to determine their ability to self-renew, differentiate into diverse cell types, and proliferate. Stem cell assays play an important role in biomedical research and regenerative medicine, with applications spanning from drug discovery and development to toxicological screening and disease modelling.

Furthermore, stem cell assays aid in drug development by determining the impact of prospective therapeutic drugs on stem cell differentiation and function. Also, these assays are utilized to research developmental processes, screen for pharmacological toxicities, and investigate disease causes such as cancer and neurological illnesses.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What are the Aspects Influencing the Growth of the Stem Cell Assay Market?

Continuous advancements in stem cell research, as well as the development of breakthrough methods for stem cell isolation, culturing, and differentiation, are key drivers. These technical advancements increase the efficiency and effectiveness of stem cell assays, making them more appealing for a variety of applications such as drug development, regenerative medicine, and fundamental research. Innovations such as 3D cell culture techniques, high-throughput screening methodologies, and advances in imaging and analytical tools all help to drive market expansion.

The growing interest in regenerative medicine, as well as the potential of stem cells to treat a variety of ailments such as cardiovascular disease, neurological disorders, and diabetes, is driving demand for stem cell assays. Governments, business companies, and academic institutions are rapidly investing in stem cell research to investigate therapeutic applications, creating a demand for tests used to assess the efficiency and safety of stem cell-based therapies.

Furthermore, the increasing global prevalence of chronic diseases and genetic disorders needs the development of new medicines and therapies. Stem cells represent a possible option for generating such treatments, increasing the demand for stem cell assays in disease modelling, drug development, and personalized medicine. The need for stem cell assays is increasing as academics and pharmaceutical companies work to better understand disease causes and test new treatments.

Will Technical Issues of Stem Cell Assay Impact the Growth of Market?

Despite advances in stem cell research, significant technical and scientific challenges remain, such as efficiently differentiating stem cells into desired cell types, maintaining the stability and purity of stem cell cultures, and ensuring assay reproducibility across multiple laboratories. These challenges have an impact on the reliability and effectiveness of stem cell assays, making it difficult to standardize techniques and generate consistent results, hence limiting market expansion.

Creating and running stem cell assays necessitates significant expenditure on specialised equipment, reagents, and expert personnel. The high costs of these assays represent a hurdle for academic institutions and small-to-medium businesses with limited resources. Furthermore, the long-term nature of stem cell research, as well as uncertainties about the commercial feasibility of stem cell-based medicines, represent major investment risks. These financial obstacles stymie the growth of the stem cell assay business, limiting its expansion.

Category-wise Acumens

What dynamics Contribute to the Dominance of Reagents and Kits Products?

According to VMR analyst, the reagents and kits segment is estimated to dominate the stem cell assay market during the forecast period. Reagents and kits are consumables used extensively in stem cell tests such as cell proliferation, differentiation, viability, and toxicity. Reagents and kits are in high demand due to their importance in daily laboratory operations and their recurrent nature. This need is being driven by continuous research and development efforts in both academic and commercial contexts, where stem cell assays are critical for drug discovery, therapeutic development, and basic research.

Reagents and kits are designed to meet a wide range of needs, from basic research to specific therapeutic areas. This versatility is strengthened by the ability to tailor kits to specific types of stem cells or tests. Such customization and application flexibility ensure that reagents and kits continue to be in high demand across a wide range of research areas and medicinal development projects, contributing to their market domination.

Furthermore, compared to instruments, which require significant initial capital investment and maintenance expenditures, reagents and kits are less expensive and more accessible to a larger range of customers, including small research labs and entrepreneurs. This decreased cost barrier promotes widespread adoption and continuing purchasing of reagents and kits, resulting in a bigger market share.

How do the Cytotoxicity Assays Influence the Growth Trajectory of the Market?

The viability or cytotoxicity assays segment is estimated to hold the largest share of the stem cell assay market during the forecast period. Viability or cytotoxicity assays are critical for determining the effects of medicines on cell health and survival, making them indispensable during the early stages of drug discovery and development. These tests assist evaluate the therapeutic index of drug candidates by analyzing their toxic effects on cells, making them critical in discovering possible treatments with the fewest cytotoxic effects.

Additionally, the expanding pharmaceutical and biotechnology companies' investment in new drug development fueling demand for these assays.

Furthermore, viability or cytotoxicity assays are versatile and can be used in a variety of research domains, including toxicology, cancer, and regenerative medicine. They are employed not just in stem cell research, but also in experiments with primary cells, cancer cells, and other cell lines. This broad applicability across several scientific and clinical sectors leads to their large market share.

Country/Region-wise Acumens

What are the Key Drivers Influencing the North American Stem Cell Assay Market?

North America is estimated to dominate the stem cell assay market during the forecast period. North America, particularly the United States, has a strong research and development infrastructure, with world-class universities, research institutions, and biotechnology and pharmaceutical corporations. This environment encourages innovation and enables ground-breaking research in stem cell technology and applications.

The presence of excellent research facilities and a highly skilled workforce facilitates the development, validation, and commercialization of stem cell assays, contributing considerably to the region's market leadership.

Furthermore, compared to other regions, North America, particularly the United States, offers a more favourable regulatory framework for stem cell research and therapeutic development. Regulatory authorities, such as the United States Food and Drug Administration (FDA), have created criteria and routes for the research and approval of stem cell-based medicines. This regulatory environment promotes innovation while maintaining safety and efficacy, making the region appealing to enterprises and researchers involved in the stem cell assay market.

What Factors Contribute to Surging Demand for Stem Cell Assays in the Asia Pacific?

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Many Asian Pacific countries have established major programs and financing schemes to encourage life science research and development, such as stem cell research and regenerative medicine. Governments in Japan, South Korea, China, and Australia are aggressively pushing stem cell research by providing direct money, establishing research centres, and forming collaborations with the commercial sector. These efforts aim to establish these countries as worldwide leaders in biotechnology and healthcare innovation, ultimately boosting the growth of the stem cell assay market.

Furthermore, Asia Pacific is experiencing an increase in the prevalence of chronic diseases such as diabetes, cardiovascular disease, and neurological disorders, owing to an ageing population. This demographic transition raises the demand for novel cures and medical treatments, particularly those based on stem cell research. Stem cell assays are crucial in the development of these therapies because they facilitate drug discovery, toxicity testing, and disease mechanism comprehension, hence promoting regional market growth.

Competitive Landscape

The competitive landscape of the stem cell assay market is defined by a dynamic interaction of many elements, such as technological breakthroughs, R&D initiatives, regulatory frameworks, and strategic alliances. Furthermore, the presence of severe regulatory requirements for stem cell research and therapeutic development emphasizes the necessity of compliance and quality assurance, which increases market rivalry.

Some of the prominent players operating in the stem cell assay market include:

Thermo Fisher Scientific

Merck KGaA

Danaher

Becton, Dickinson and Company

Bio-Rad Laboratories

PerkinElmer

Agilent Technologies

Promega Corporation

Cell Biolabs

Miltenyi Biotec

STEMCELL Technologies

Bio-Techne Corporation

FUJIFILM Holdings Corporation

Sartorius Stedim Biotech

GE Healthcare

Roche Diagnostics

Latest Developments:

In February 2024, Thermo Fisher, a prominent market player, introduced an innovative serum-free stem cell culture medium that claims to promote stem cell multiplication and differentiation. This could be a huge advancement for companies developing stem cell medicines.

In February 2024, Danaher, another significant competitor, purchased a company that specializes in cell analysis technology. Danaher's position in the stem cell assay industry could be strengthened by this acquisition, which will provide improved stem cell characterization tools.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STEM CELL ASSAY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL STEM CELL ASSAY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL STEM CELL ASSAY MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Reagents and Kits
• 5.3 Instruments

6 GLOBAL STEM CELL ASSAY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Regenerative Medicine and Therapy
• 6.3 Clinical Research
• 6.4 Drug Discovery and Development

7 GLOBAL STEM CELL ASSAY MARKET, BY ASSAY

• 7.1 Overview
• 7.2 Cell Identification Assays
• 7.3 Viability or Cytotoxicity Assays
• 7.4 Apoptosis Assays
• 7.5 Isolation & Purification Assays
• 7.6 Others

8 GLOBAL STEM CELL ASSAY MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL STEM CELL ASSAY MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Thermo Fisher Scientific
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Perkinelmer
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Stemcell Technologies
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Merck
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Bio-Rad Laboratories
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Agilent Technologies
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments

11 Appendix

• 11.1 Related Research